๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Novel lenalidomide-based combinations for treatment of multiple myeloma

โœ Scribed by Mauro Cives; Valeria Simone; Oronzo Brunetti; Vito Longo; Franco Silvestris

Book ID
119222915
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
653 KB
Volume
85
Category
Article
ISSN
1040-8428

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Future drug developments in multiple mye
Future drug developments in multiple myeloma: an overview of novel lenalidomide-based combination therapies
โœ Gareth Morgan ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 214 KB

The introduction of thalidomide, lenalidomide, and bortezomib has changed the way that multiple myeloma (MM) is treated and has greatly improved survival outcomes. These novel agents are often used in combination with conventional drugs, such as dexamethasone, to optimize clinical responses; however

Thromboembolic events with lenalidomide-
Thromboembolic events with lenalidomide-based therapy for multiple myeloma
โœ Smitha Patiyil Menon; S. Vincent Rajkumar; Martha Lacy; Patrizia Falco; Antonio ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 87 KB

## Abstract ## BACKGROUND. The purpose was to evaluate the incidence and risk factors of thromboembolism associated with lenalidomide therapy in newly diagnosed myeloma. ## METHODS. A pooled analysis was performed of patients with previously untreated multiple myeloma enrolled in clinical trials